Faculty profile

Paaladinesh Thavendiranathan

ResearcherCardiologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Paaladinesh Thavendiranathan

Researcher

Cardiology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
94 publications in the last five years, latest in 2026.
Senior (last) author on 19 recent papers, a sign of leading a research group.
Principal investigator on 9 research grants (9 CIHR), most recently in 2024.
Supervised 1 trainee who won CIHR awards, most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

222

Publications

328

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Heart Failure Cardiac Toxicity Myocardial Strain Cardiotoxicity Cardiac Troponin Echocardiography Myocardial Edema

Latest papers

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.
Cancer · 2026
Managing an elevated troponin in a patient on immune checkpoint inhibitors.
The Canadian journal of cardiology · 2026 · senior author
Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.
JACC. Advances · 2026

All 222 publications

Latest funding

The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2025 · Co-investigator
$1,487,925
Tumour-dependent mechanisms of cardiotoxicity during cancer therapy
CIHR · 2024 · Principal investigator
$1,143,675
The JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY) Randomized Controlled Trial
CIHR · 2024 · Co-investigator
$100,000

All 16 grants and awards

From the 150 most recent of 222 publications.

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Icht O, Nardi-Agmon I, Thavendiranathan P, Keshavjee S, Agrawal A, Miro JM, Badran O, Liu G, Ye XY, Cho BCJ, Bezjak A, Hope A

Cancer2026

DOI: 10.1002/cncr.70595 PMID: 42691203

Managing an elevated troponin in a patient on immune checkpoint inhibitors.

Sen J, El-Rayes M, Salem JE, Abdel-Qadir H, Thavendiranathan P

The Canadian journal of cardiology2026Senior author

DOI: 10.1016/j.cjca.2026.01.059 PMID: 41651209

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

Chauhan A, Giannakeas V, Thiruchelvam D, Thavendiranathan P, Amir E, Nadler MB, Savard MF, Abdel-Qadir H

JACC. Advances2026

DOI: 10.1016/j.jacadv.2026.102937 PMID: 42489382

The Burden of Cardiovascular Disease in Lymphoma Survivors: A Population-Based Matched Cohort Study.

Yu C, Chen Y, Halajha G, Prica A, Vijenthira A, Fang J, Austin PC, Thavendiranathan P, Abdel-Qadir H

JACC. Advances2026

DOI: 10.1016/j.jacadv.2026.102860 PMID: 42335595

Field strength dependence, physiologic correlates, and prognostic significance of ventricular blood pool T2 mapping on cardiovascular magnetic resonance imaging.

Iarovich MD, Ibrahim F, Matos JF, de Silva N, Lowes WH, Moayedi Y, Thavendiranathan P, Emrich T, Varga-Szemes A, Hanneman K

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2026

DOI: 10.1016/j.jocmr.2026.102760 PMID: 42251966

Sex-Specific Associations between Long-term Air Pollution Exposure and Coronary Atherosclerosis at Cardiac CT.

Castillo F, Ladak AM, DesRoche C, Delaney S, Nethery RC, Thavendiranathan P, Ross H, Hanneman K

Radiology2026

DOI: 10.1148/radiol.252086 PMID: 42262238

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort Study.

Nardi Agmon I, Gurevitz C, Shochat T, Kushnir S, Witberg G, Levi A, Gilon D, Kornowski R, Thavendiranathan P, Abdel Qadir H, Iakobishvili Z

Clinical pharmacology and therapeutics2026

DOI: 10.1002/cpt.70232 PMID: 41665248

Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations: JACC: CardioOncology State-of-the-Art Review.

Sen J, Amir E, Austin PC, Marwick TH, McIntosh C, Thavendiranathan P, Abdel-Qadir H

JACC. CardioOncology2026

DOI: 10.1016/j.jaccao.2026.01.006 PMID: 42017562

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

Nakajima E, Nguyen L, Liu N, Rodin D, Amir E, Austin PC, Thavendiranathan P, Abdel-Qadir H

JAMA network open2026

DOI: 10.1001/jamanetworkopen.2026.4098 PMID: 41920543

The Risk of Cardiovascular Adverse Outcomes in Patients With Thymoma or Thymic Carcinoma Receiving Cancer Therapy.

Nardi Agmon I, Zhan LJ, Ho G, Foroutan F, Power C, Bezjak A, Keshavjee S, Icht O, Miro J, Abdel-Qadir H, Hope A, Liu G, Thavendiranathan P

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2026Senior author

DOI: 10.1016/j.jtho.2025.12.002 PMID: 41371606

Something wrong or missing on this profile? Suggest a correction

Paaladinesh Thavendiranathan

Research

Latest papers

Latest funding

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Managing an elevated troponin in a patient on immune checkpoint inhibitors.

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

The Burden of Cardiovascular Disease in Lymphoma Survivors: A Population-Based Matched Cohort Study.

Field strength dependence, physiologic correlates, and prognostic significance of ventricular blood pool T2 mapping on cardiovascular magnetic resonance imaging.

Sex-Specific Associations between Long-term Air Pollution Exposure and Coronary Atherosclerosis at Cardiac CT.

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort Study.

Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations: JACC: CardioOncology State-of-the-Art Review.

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

The Risk of Cardiovascular Adverse Outcomes in Patients With Thymoma or Thymic Carcinoma Receiving Cancer Therapy.

Frequent collaborators

Kate Hanneman

Eitan Amir

Filio Billia

Yasbanoo Moayedi

Paul Dorian

Kumaraswamy Nanthakumar

Chris McIntosh

Brian Wong

Paul Yip

Heather Ross

Andrew Hope

Paul Oh

Fernando Rivera-Theurel

Adrian Sacher

Geoff Anderson

Amer Johri

Davor Brinc

Michael Farkouh

Darryl Leong

Shaf Keshavjee

Jonathan Afilalo

Danielle Rodin

Stephanie Lheureux

Jennifer Chung

Marie-France Savard

Hassan Mir

Howard Leong-Poi

Aaron Schimmer

Milica Radisic

John Dick

Farid Foroutan

Andrew Baker

Peter Kavsak

Moran Drucker Iarovich

Amna Al-arnawoot

Nazanin Aghel

Geoffrey Liu